跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RIVA-TELMISARTAN/AMLODIPINE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
RIVA-TELMISARTAN/AMLODIPINE
Authorized
STANDARD
RIVA-TELMISARTAN/AMLODIPINE
LABORATOIRE RIVA INC.
🇨🇦 Health Canada
Approval Date
Apr 6, 2026
Approval ID
a8b6e14dd0f75c56
Company
LABORATOIRE RIVA INC.
Type
Standard
Approval Details
Approval Id
a8b6e14dd0f75c56
Drug Approval Canada Name
RIVA-TELMISARTAN/AMLODIPINE
Product Name
RIVA-TELMISARTAN/AMLODIPINE
Status
Marketed
Status Date
2025-11-13
Original Market Date
2025-11-13
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
PRESCRIPTION
Ahfs
24:28.08 , 24:32.08
Atc Original
C09DB04 TELMISARTAN AND AMLODIPINE
Aig Number
0252947001
Company Name
LABORATOIRE RIVA INC.
Company Address
660 Boul. Industriel Blainville Quebec Canada J7C 3V4
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Apr 6, 2026
Approval ID
a8b6e14dd0f75c56
Type
Standard
Back to Health Canada Approvals